CTTHOTCPharmaceutical PreparationsFiscal year ends December 31
CTT PHARMACEUTICAL HOLDINGS, INC.
Financials through Q3 FY2015, quarter ended Sep 30, 2015Last filing: 10-Q on Sep 17, 2026
$0.06−0.00 (-0.17%)
Close on Oct 16, 2026
- Market cap
- $1.26M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.0041 (−6.51%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Sep 30, 2015
Valuation
- Market cap
- $1.26M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 1.70
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$1.67M
- EPS, diluted
- -$0.03
- Book value per share
- $0.03
- Diluted shares
- 21M
Fifteen years at a glance
Fiscal years 2000 to 2014 and trailing twelve months, USD
Operating income
–
Net income
-$1.67M
EPS, diluted
-$0.03
Reported periodTrailing twelve months